NCT00064870 · RECRUITING

Alzheimer's Disease Genetics Study

This study collects blood or tissue samples from families with several members who have Alzheimer's or another dementia. Researchers want to find genes that influence late-onset Alzheimer's. No drug or treatment is being given. It is a genetics collection effort, so no phase applies. Details are limited so far.

Eligibility criteria

Inclusion Criteria:
* Two living family members diagnosed with AD or other dementia with any age of onset
* Biological samples available
  * Fresh blood, or
  * Immortalized lymphoblastic cell lines, or
  * 3-5 grams of frozen cerebral cortex; fixed samples are not accepted
Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.
Exclusion Criteria:
* Does not meet inclusion criteria
* Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-09-08

View full record on ClinicalTrials.gov

All APOE4 clinical trials